8-KEarnings & ResultsExhibits & Filings

BOSTON SCIENTIFIC CORP 8-K Report, Financial Results (Apr 27, 2016)

Filed April 27, 2016For Securities:BSX

Summary

Boston Scientific Corporation (BSX) has filed an 8-K report on April 27, 2016, primarily to furnish a press release announcing their first quarter financial results for the period ended March 31, 2016. This filing is important for investors as it provides the company's latest operational and financial performance data. The press release, attached as Exhibit 99.1, details the company's revenue, earnings, and other key financial metrics, offering insights into the company's performance and outlook. While the 8-K itself is brief and mainly serves to attach the press release, investors should carefully review the furnished press release (Exhibit 99.1) for a comprehensive understanding of Boston Scientific's Q1 2016 financial condition. This includes examining revenue growth across different business segments, profitability trends, and any forward-looking statements or guidance provided by the company. This information is crucial for assessing the company's strategic direction and investment potential.

Key Highlights

  • 1Boston Scientific Corporation (BSX) reported its first quarter 2016 financial results on April 27, 2016, via an 8-K filing.
  • 2The primary purpose of the 8-K filing was to furnish a press release detailing the Q1 2016 financial performance.
  • 3Investors can find detailed financial information, including revenue and earnings, within the attached press release (Exhibit 99.1).
  • 4The filing serves as an official notification of the company's latest financial performance update.
  • 5Information furnished under Item 2.02 is not considered 'filed' for Section 18 of the Exchange Act, meaning it doesn't carry the same legal liabilities for misstatements.
  • 6The report includes no new material business events or transactions beyond the financial results announcement.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially announce and provide Boston Scientific Corporation's financial results for the first quarter ended March 31, 2016. The detailed results are contained within an attached press release.

The detailed financial results, including revenue, earnings, and other performance metrics for the first quarter of 2016, are located in the press release furnished as Exhibit 99.1 to this 8-K filing.

No, the information contained in Item 2.02 of this Current Report and Exhibit 99.1 is furnished and not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934. This means it does not carry the same legal liabilities as 'filed' information.

This specific 8-K filing focuses solely on the announcement of the company's first quarter 2016 financial results. It does not appear to contain information about other material business events or corporate changes.